Njikọ na Ụzọ: Mmekọ, Nkwekọ na Mmeri-Mmeri
ngwaahịa

Ngwaahịa

Pitavastatin CAS:147511-69-1 Onye Na-eweta Ngwaahịa

Pitavastatin bụ ihe na-egbochi HMG-CoA reductase nke na-akwalite usoro mbụ nke mmepụta cholesterol. Ọ na-adị ka ntụ ntụ na-enweghị isi ma na-acha ọcha ruo na-acha odo odo. Ọ na-arụ ọrụ site n'ibelata ọkwa nke ụfọdụ ihe abụba dị ka cholesterol n'ahụ. Ya mere, a na-egosi ya karịsịa maka ọgwụgwọ hypercholesterolemia na maka igbochi ọrịa obi. Ọ bụghị naanị na ọ nwere ike ibelata cholesterol dị elu na triglyceride n'ime ụfọdụ ndị ọrịa, kamakwa ọ nwere ike ịbawanye ọdịnaya nke lipoprotein dị elu (HDL), ọkwa cholesterol "dị mma". A ga-ejikarị ya na nri kwesịrị ekwesị.


Nkọwa Ngwaahịa

Akara Ngwaahịa

Ngwa na Mmetụta

Pivastatin bụ ọgwụ na-egbochi oke abụba. Ọ bụghị naanị ọgwụ ọhụrụ, dị irè, dị nchebe, ma dị na kemịkalụ nke e ji statin mee, nke na-ebelata oke abụba, kamakwa ọ bụ ihe na-egbochi 3-hydroxy-3-methylglutaryl CoA (HMG-CoA reductase) reductase. Ọ bụghị naanị na ọ nwere mmetụta siri ike na ibelata LDL-C na TC, kamakwa ọ nwere nnukwu polymorphism mkpụrụ ndụ ihe nketa, nnukwu bioavailability, na ogologo ọkara ndụ. Ọ bụ naanị mmadụ ole na ole na-enweta metabolism CYP2C9. A na-eji ya agwọ hyperlipidemia mbụ, hypercholesterolemia ezinụlọ, na nsogbu lipid agwakọtara.

Ihe Nlereanya Ngwaahịa

图片336(1)
图片337(1)

Nkwakọ ngwaahịa:

图片338(1)

Ozi Mgbakwunye:

Ihe mejupụtara ya C25H24FNO4
Nnwale 99%
Ọdịdị Ntụ ntụ ọcha ruo na ntụ ọcha na-adịghị ọcha
Nọmba CAS 147511-69-1
Nkwakọ ngwaahịa 25KG
Ndụ nchekwa afọ 2
Nchekwa Debe n'ebe dị jụụ ma kpọọ nkụ
Asambodo ISO.

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a zitere anyị ya